Conditions: Malignant Solid Tumors, Moderate to High Emetogenic Chemotherapy (MEC/HEC) Drugs
Locations: The First Affiliated Hospital of Xinxiang Medical University Xinxiang, Henan, China

Completed

NCT05930457

Conditions: Malignant Solid Tumors
Locations: The First Affiliated Hospital of Guangzhou Medical University Guangzhou, China

Completed

NCT05814835

Conditions: Malignant Solid Tumors
Locations: the First Medical Center, Chinese PLA General Hospital Beijing, China

Completed

NCT05594147

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Disease 2019 (COVID-19), +12 more
Locations: Bayer Whippany, New Jersey, United States

Completed

NCT03205176

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +38 more
Locations: Research Site Sarasota, Florida, United States

Research Site Oklahoma City, Oklahoma, United States

Research Site Nashville, Tennessee, United States

Research Site Toronto, CA, Canada

Completed

NCT01765790

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +10 more
Locations: Scottsdale Healthcare Scottsdale, Arizona, United States

Florida Cancer Specialists / Sarah Cannon Research Institute Sarasota, Florida, United States

Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center Houston, Texas, United States

Cancer Therapy and Research Center (CTRC), The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States

Completed

NCT02902237

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University Hospital Muenster Münster, North Rhine-Westphalia, Germany

Completed

NCT01519817

Conditions: Adenocarcinoma, Carcinoma, Colon Neoplasms, +14 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

Malignant Solid Tumors

Malignant Solid Tumors trial results